Complications following intravenous administration of solutions containing xylitol.
D000138:Acidosis / Q000139:chemically induced; D000293:Adolescent; D000328:Adult; D000368:Aged; D001002:Anuria / Q000139:chemically induced; D001639:Bicarbonates / Q000097:blood; D002118:Calcium / Q000032:analysis; D002245:Carbon Dioxide / Q000097:blood; D055598:Chemical Phenomena; D056486:Chemical and Drug Induced Liver Injury; D002621:Chemistry; D005260:Female; D006801:Humans; D006863:Hydrogen-Ion Concentration; D008099:Liver / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D009461:Neurologic Manifestations; D009584:Nitrogen / Q000097:blood; D010070:Oxalates / Q000032:analysis; D010288:Parenteral Nutrition / Q000009:adverse effects; D012996:Solutions; D014511:Uremia / Q000139:chemically induced; D014527:Uric Acid / Q000097:blood; D014882:Water-Electrolyte Balance; D014993:Xylitol / Q000008:administration & dosage / Q000009:adverse effects*
D001639:Bicarbonates; D010070:Oxalates; D012996:Solutions; D002245:Carbon Dioxide; D014527:Uric Acid; D009584:Nitrogen; D002118:Calcium; D014993:Xylitol